

Need a doctor who prescribes Ibrutinib? Learn which specialists prescribe it, how to find one near you, and what to expect at your first appointment.
Ibrutinib (brand name Imbruvica) is a targeted cancer medication used to treat certain blood cancers and chronic graft-versus-host disease. Unlike medications you might get from a family doctor, Ibrutinib requires a specialist — and finding the right one can feel overwhelming, especially if you've just been diagnosed.
This guide walks you through who prescribes Ibrutinib, how to find a qualified provider near you, and what to expect when you get there.
Ibrutinib is a specialty oncology medication. It is not something your primary care doctor will typically prescribe. The specialists who prescribe it include:
In most cases, you will need a referral from your primary care doctor or another physician to see one of these specialists.
There are several ways to find a hematologist-oncologist or other specialist near you who can evaluate whether Ibrutinib is right for your condition.
This is the most common route. If your blood work or symptoms suggest a blood cancer, your primary care doctor will refer you to a hematologist-oncologist. They can usually recommend someone in your area who has experience treating your specific condition.
Log into your health insurance website or call the number on the back of your insurance card. Search for in-network hematologists or oncologists near your zip code. This ensures you'll get the best coverage for specialist visits and for the medication itself.
Several online tools can help you find specialists:
If you live near a major medical center or NCI-designated cancer center, they will have hematology-oncology departments staffed with doctors who regularly prescribe Ibrutinib and similar targeted therapies. Academic medical centers often have the most experience with newer treatments.
While your initial evaluation and diagnosis will likely need to be in person, some follow-up visits and medication management may be available through telehealth depending on your provider and state regulations. Ask your specialist if they offer virtual appointments for ongoing monitoring.
When you see a hematologist-oncologist for the first time, here's what typically happens:
Bring a list of all medications, supplements, and over-the-counter drugs you currently take. Ibrutinib has significant drug interactions, so this information is critical.
Once your doctor prescribes Ibrutinib, the process looks a bit different from picking up a typical medication at your local pharmacy.
Ibrutinib is dispensed through specialty pharmacies, not regular retail pharmacies. Your doctor's office or insurance company will direct you to an approved specialty pharmacy. These pharmacies specialize in high-cost, complex medications and often provide:
Ibrutinib costs approximately $14,000 to $18,000 per month without insurance. Even with insurance, copays can be substantial. Here are some resources:
For more details, read our guide on how to save money on Ibrutinib.
If you're having trouble locating Ibrutinib at a pharmacy, Medfinder can help you check availability without calling around. You can also read our guide on how to check if a pharmacy has Ibrutinib in stock.
Finding the right doctor to prescribe Ibrutinib is the first step in your treatment journey. Start with your primary care doctor for a referral, use your insurance directory to find in-network specialists, and don't hesitate to reach out to cancer centers or patient advocacy organizations for help.
Once you have a specialist and a prescription, resources like Medfinder can help you locate the medication and manage costs. You don't have to navigate this alone.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.